Oragenics (OGEN) Accumulated Expenses (2012 - 2024)
Oragenics' (OGEN) quarterly Accumulated Expenses came in at $8399.0 in Q4 2024, up 5.24% YoY from $7981.0 in Q1 2024, and down 70.18% on a QoQ basis from $28170.0 in Q3 2024.
Oragenics (OGEN) Accumulated Expenses (2012 - 2024) Analysis & Trends
Oragenics (OGEN) has 13 years of Accumulated Expenses data on file, last reported at $8399.0 in Q4 2024.
- Quarterly Accumulated Expenses rose 5.24% year-over-year to $8399.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $8399.0 (up 5.24% YoY) and the FY2024 annual result came in at $8399.0, up 5.24% from the prior year.
- Accumulated Expenses retreated to $8399.0 in Q4 2024, from $28170.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $812861.0 in Q4 2022 to a low of $7981.0 in Q4 2023.
- A 5-year average of $132757.4 and a median of $30139.0 in 2023 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 1308.01% — and 2023, when it sank 99.02%.
- Tracing OGEN's Accumulated Expenses over 5 years: stood at $247683.0 in 2020, then tumbled by 76.69% to $57731.0 in 2021, then jumped by 1308.01% to $812861.0 in 2022, then slumped by 99.02% to $7981.0 in 2023, then rose by 5.24% to $8399.0 in 2024.
- The last three Accumulated Expenses figures came in at $8399.0 (Q4 2024), $28170.0 (Q3 2024), and $180955.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oragenics | 2.31 Mn | 2.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8,399.00 |
| Sep 30, 2024 | 28,170.00 |
| Jun 30, 2024 | 180,955.00 |
| Mar 31, 2024 | 17,290.00 |
| Dec 31, 2023 | 7,981.00 |
| Sep 30, 2023 | 30,139.00 |
| Jun 30, 2023 | 26,002.00 |
| Mar 31, 2023 | 43,120.00 |
| Dec 31, 2022 | 812,861.00 |
| Dec 31, 2021 | 57,731.00 |
| Dec 31, 2020 | 247,683.00 |
| Dec 31, 2019 | 143,095.00 |
| Dec 31, 2018 | 123,268.00 |
| Dec 31, 2017 | 106,722.00 |
| Dec 31, 2016 | 93,361.00 |
| Dec 31, 2015 | 25,500.00 |
| Dec 31, 2014 | 25,500.00 |
| Dec 31, 2013 | 25,500.00 |
| Dec 31, 2012 | 25,500.00 |